Evidence map›Paper›PMID 38826344›Full record

ArticlebioRxiv : the preprint server for biology2025

Cardiolipin dynamics promote membrane remodeling by mitochondrial OPA1.

Sirikrishna Thatavarthy, Luciano A Abriata, Fernando Teixeira Pinto Meireles, Kelly E Zuccaro, Akhil Gargey Iragavarapu, Gabriela May Sullivan, Frank R Moss, Adam Frost, Matteo Dal Peraro, Halil Aydin

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sirikrishna ThatavarthyDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, USA.
Luciano A AbriataInstitute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Fernando Teixeira Pinto MeirelesInstitute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Kelly E ZuccaroDepartment of Biochemistry, University of Colorado Boulder, Boulder, Colorado, USA.
Akhil Gargey IragavarapuDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, USA.ORCID 0000-0002-0483-7639
Gabriela May SullivanDepartment of Biochemistry, University of Colorado Boulder, Boulder, Colorado, USA.
Frank R MossAltos Labs, Bay Area Institute of Science, San Francisco, CA, USA.
Adam FrostAltos Labs, Bay Area Institute of Science, San Francisco, CA, USA.
Matteo Dal PeraroInstitute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.ORCID 0000-0002-2973-3975
Halil AydinDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, USA.ORCID 0000-0002-5409-3797

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Regulation of mitochondrial morphology and functional versatilityR35GM150942 · NIGMS · UNIVERSITY OF COLORADO · PI HALIL AYDIN · 2023 to 2026
$1.6M
Regulated Mitochondrial MorphologyR01GM127673 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BULKLEY, DAVID · 2018 to 2021
$1.2M
NCI NIH HHS P30 CA016087NIGMS NIH HHS R01 GM127673NIGMS NIH HHS R35 GM150942
6 · The paper itself

Abstract

Cardiolipin (CL) is a mitochondria-specific phospholipid that forms heterotypic interactions with membrane-shaping proteins and regulates the dynamic remodeling and function of mitochondria. However, the precise mechanisms through which CL influences mitochondrial morphology are not well understood. In this study, employing molecular dynamics (MD) simulations, we determined that CL molecules extensively engage with the paddle domain (PD) of mitochondrial fusion protein Optic Atrophy 1 (OPA1), which controls membrane-shaping mechanisms. Structure-function analysis confirmed the interactions between CL and two conserved motifs of OPA1 at the membrane-binding sites. We further developed a bromine-labeled CL probe to enhance cryoEM contrast and characterized the structure of OPA1 assemblies bound to the CL-brominated lipid bilayers. Our images provide direct evidence of CL enrichment within the OPA1-binding leaflet. Last, we observed a decrease in membrane remodeling activity for OPA1 in lipid compositions with increasing concentrations of monolyso-cardiolipin (MLCL). This suggests that the partial replacement of CL by MLCL, as observed in Barth syndrome-associated mutations of the tafazzin phospholipid transacylase, alters the malleability of the membrane and compromises proper remodeling. Together, these data provide insights into how biological membranes regulate the mechanisms governing mitochondrial homeostasis.

Identifiers

PMID38826344
PMCPMC11142133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.